UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical-grade manufacturing of autologous mature mRNA-electroporated dendritic cells and safety testing in acute myeloid leukemia patients in a phase I dose-escalation clinical trial

Cytotherapy (Oxford, England), 2009, Vol.11 (5), p.653-668

2009

Volltextzugriff (PDF)

Immunotherapy of Acute Myeloid Leukemia: Current Approaches

The oncologist (Dayton, Ohio), 2009-03, Vol.14 (3), p.240-252

2009

Volltextzugriff (PDF)

NK Cells: Key to Success of DC‐Based Cancer Vaccines?

The oncologist (Dayton, Ohio), 2012-10, Vol.17 (10), p.1256-1270

2012

Volltextzugriff (PDF)

Induction of cytomegalovirus-specific T cell responses in healthy volunteers and allogeneic stem cell recipients using vaccination with messenger RNA-transfected dendritic cells

Transplantation, 2015-01, Vol.99 (1), p.120-127

2015

Volltextzugriff (PDF)

Interleukin-15: New kid on the block for antitumor combination therapy

Cytokine & growth factor reviews, 2015-02, Vol.26 (1), p.15-24

2015

Volltextzugriff (PDF)

Dendritic cell-based cancer gene therapy

Human gene therapy, 2009-10, Vol.20 (10), p.1106-1118

2009

Volltextzugriff (PDF)

Human C-reactive protein activates monocyte-derived dendritic cells and induces dendritic cell-mediated T-cell activation

Arteriosclerosis, thrombosis, and vascular biology, 2008-03, Vol.28 (3), p.511-518

2008

Volltextzugriff (PDF)

Except for C-C chemokine receptor 7 expression, monocyte-derived dendritic cells from patients with multiple sclerosis are functionally comparable to those of healthy controls

Cytotherapy (Oxford, England), 2014-07, Vol.16 (7), p.1024-1030

2014

Volltextzugriff (PDF)

Dendritic cell vaccine therapy for acute myeloid leukemia: Questions and answers

Human vaccines, 2011-05, Vol.7 (5), p.579-584

2011

Volltextzugriff (PDF)

Chimeric Antigen Receptor-Modified T Cell Therapy in Multiple Myeloma: Beyond B Cell Maturation Antigen

Frontiers in immunology, 2019-07, Vol.10, p.1613-1613

2019

Volltextzugriff (PDF)

Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer

Frontiers in immunology, 2018-03, Vol.9, p.394-394

2018

Volltextzugriff (PDF)

The Use of TLR7 and TLR8 Ligands for the Enhancement of Cancer Immunotherapy

The oncologist (Dayton, Ohio), 2008-08, Vol.13 (8), p.859-875

2008

Volltextzugriff (PDF)

The DFNA5 gene, responsible for hearing loss and involved in cancer, encodes a novel apoptosis-inducing protein

European journal of human genetics : EJHG, 2011-09, Vol.19 (9), p.965-973

2011

Volltextzugriff (PDF)

Acute myeloid leukemic cell lines loaded with synthetic dsRNA trigger IFN-γ secretion by human NK cells

Leukemia research, 2009-04, Vol.33 (4), p.539-546

2009

Volltextzugriff (PDF)

Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cells

Journal of leukocyte biology, 2007-12, Vol.82 (6), p.1365-1374

2007

Volltextzugriff (PDF)

mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients

AIDS (London), 2012-02, Vol.26 (4), p.F1-F12

2012

Volltextzugriff (PDF)

Active Specific Immunotherapy Targeting the Wilms' Tumor Protein 1 (WT1) for Patients with Hematological Malignancies and Solid Tumors: Lessons from Early Clinical Trials

The oncologist (Dayton, Ohio), 2012, Vol.17 (2), p.250-259

2012

Volltextzugriff (PDF)

The Ins and Outs of Messenger RNA Electroporation for Physical Gene Delivery in Immune Cell-Based Therapy

Pharmaceutics, 2021-03, Vol.13 (3), p.396

2021

Volltextzugriff (PDF)

Rapid Assessment of Functional Avidity of Tumor-Specific T Cell Receptors Using an Antigen-Presenting Tumor Cell Line Electroporated with Full-Length Tumor Antigen mRNA

Cancers, 2020-01, Vol.12 (2), p.256

2020

Volltextzugriff (PDF)

A maximal exercise bout increases the number of circulating CD34+/KDR+ endothelial progenitor cells in healthy subjects. Relation with lipid profile

Journal of applied physiology (1985), 2008-04, Vol.104 (4), p.1006-1013

2008

Volltextzugriff (PDF)

Monocyte-Derived Dendritic Cells with Silenced PD-1 Ligands and Transpresenting Interleukin-15 Stimulate Strong Tumor-Reactive T-cell Expansion

Cancer immunology research, 2017-08, Vol.5 (8), p.710-715

2017

Volltextzugriff (PDF)

Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells

Blood, 2001-07, Vol.98 (1), p.49-56

2001

Volltextzugriff (PDF)

Engineering monocyte-derived dendritic cells to secrete interferon-α enhances their ability to promote adaptive and innate anti-tumor immune effector functions

Cancer Immunology, Immunotherapy, 2015-07, Vol.64 (7), p.831-842

2015

Volltextzugriff (PDF)

Poly(I:C) enhances the susceptibility of leukemic cells to NK cell cytotoxicity and phagocytosis by DC

PloS one, 2011-06, Vol.6 (6), p.e20952-e20952

2011

Volltextzugriff (PDF)

Toll-like receptor 7/8 agonist resiquimod greatly increases the immunostimulatory capacity of human acute myeloid leukemia cells

Cancer Immunology, Immunotherapy, 2010-01, Vol.59 (1), p.35-46

2010

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(50)

Sprache

Englisch
(50)

Erscheinungsjahr

n.n

Thema

Science & Technology
(42)
Life Sciences & Biomedicine
(41)
Humans
(39)
Dendritic Cells - Immunology
(20)
Immunology
(18)
Oncology
(16)
Electroporation
(15)
Immunotherapy
(14)
Dendritic Cells
(13)
Biological And Medical Sciences
(12)
Female
(10)
Adult
(9)
Hematology
(9)
Male
(9)
Medical Sciences
(9)
Animals
(8)
Cancer Vaccines - Immunology
(8)
Cd8-Positive T-Lymphocytes - Immunology
(8)
Biotechnology & Applied Microbiology
(7)
Cancer
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinical-grade manufacturing of autologous mature mRNA-electroporated dendritic cells and safety testing in acute myeloid leukemia patients in a phase I dose-escalation clinical trial

Immunotherapy of Acute Myeloid Leukemia: Current Approaches

NK Cells: Key to Success of DC‐Based Cancer Vaccines?

Induction of cytomegalovirus-specific T cell responses in healthy volunteers and allogeneic stem cell recipients using vaccination with messenger RNA-transfected dendritic cells

Interleukin-15: New kid on the block for antitumor combination therapy

Dendritic cell-based cancer gene therapy

Human C-reactive protein activates monocyte-derived dendritic cells and induces dendritic cell-mediated T-cell activation

Except for C-C chemokine receptor 7 expression, monocyte-derived dendritic cells from patients with multiple sclerosis are functionally comparable to those of healthy controls

Dendritic cell vaccine therapy for acute myeloid leukemia: Questions and answers

Chimeric Antigen Receptor-Modified T Cell Therapy in Multiple Myeloma: Beyond B Cell Maturation Antigen

Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer

The Use of TLR7 and TLR8 Ligands for the Enhancement of Cancer Immunotherapy

The DFNA5 gene, responsible for hearing loss and involved in cancer, encodes a novel apoptosis-inducing protein

Acute myeloid leukemic cell lines loaded with synthetic dsRNA trigger IFN-γ secretion by human NK cells

Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cells

mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients

Active Specific Immunotherapy Targeting the Wilms' Tumor Protein 1 (WT1) for Patients with Hematological Malignancies and Solid Tumors: Lessons from Early Clinical Trials

The Ins and Outs of Messenger RNA Electroporation for Physical Gene Delivery in Immune Cell-Based Therapy

Rapid Assessment of Functional Avidity of Tumor-Specific T Cell Receptors Using an Antigen-Presenting Tumor Cell Line Electroporated with Full-Length Tumor Antigen mRNA

A maximal exercise bout increases the number of circulating CD34+/KDR+ endothelial progenitor cells in healthy subjects. Relation with lipid profile

Monocyte-Derived Dendritic Cells with Silenced PD-1 Ligands and Transpresenting Interleukin-15 Stimulate Strong Tumor-Reactive T-cell Expansion

Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells

Engineering monocyte-derived dendritic cells to secrete interferon-α enhances their ability to promote adaptive and innate anti-tumor immune effector functions

Poly(I:C) enhances the susceptibility of leukemic cells to NK cell cytotoxicity and phagocytosis by DC

Toll-like receptor 7/8 agonist resiquimod greatly increases the immunostimulatory capacity of human acute myeloid leukemia cells

Suchergebnisse filtern